Simeoni S, Scalia S, Benson H A E
Department of Pharmaceutical Sciences, University of Ferrara, Via Fossato di Mortara 17, 44100 Ferrara, Italy.
Int J Pharm. 2004 Aug 6;280(1-2):163-71. doi: 10.1016/j.ijpharm.2004.05.021.
The effects of hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and sulfobutylether-beta-CD (SBE7-beta-CD) on in vitro human skin penetration and retention of the sunscreen agent butyl-methoxydibenzoylmethane (BM-DBM) were investigated. The interaction between the UV filter and the cyclodextrins was studied in water by phase-solubility analysis. Solid complexes were prepared by the co-evaporation method and characterized by (1)H NMR spectroscopy, thermal analysis and powder X-ray diffraction. Solutions containing BM-DBM free or complexed with cyclodextrins were applied to excised human skin in Franz diffusion cells and the amount of sunscreen permeated after 6 h into the stratum corneum, viable epidermis, dermis and receptor fluid was assessed by HPLC. As much as 14.10-16.78% of the applied dose of BM-DBM penetrated within the skin tissue. No sunscreen was detected in the dermis and in the receiver phase. The greater proportion (84.6-95.5%) of the absorbed UV filter was localized in the stratum corneum with no significant differences between uncomplexed or complexed BM-DBM. Notable levels (2.29% of the applied dose) of the sunscreen agent accumulated in the epidermis from the preparation containing free BM-DBM. The epidermal concentration of the UV filter was markedly reduced (0.66% of the applied dose) by complexation with SBE7-beta-CD, whereas HP-beta-CD had no effect. The decreased BM-DBM retention in the epidermal region achieved by SBE7-beta-CD limits direct contact of the sunscreen and of its reactive photolytic products with the skin viable tissues.
研究了羟丙基-β-环糊精(HP-β-CD)和磺丁基醚-β-环糊精(SBE7-β-CD)对防晒剂丁基甲氧基二苯甲酰甲烷(BM-DBM)体外透皮及皮肤滞留的影响。通过相溶解度分析研究了紫外线过滤剂与环糊精之间在水中的相互作用。采用共蒸发法制备了固体复合物,并通过核磁共振氢谱(¹H NMR)、热分析和粉末X射线衍射对其进行了表征。将含有游离BM-DBM或与环糊精复合的BM-DBM的溶液应用于Franz扩散池中切除的人体皮肤,通过高效液相色谱法(HPLC)评估6小时后渗透到角质层、活性表皮、真皮和受体液中的防晒剂含量。BM-DBM给药剂量的14.10 - 16.78%渗透到皮肤组织中。在真皮和接受相中未检测到防晒剂。吸收的紫外线过滤剂中较大比例(84.6 - 95.5%)位于角质层,未复合或复合的BM-DBM之间无显著差异。从含有游离BM-DBM的制剂中,有显著水平(给药剂量的2.29%)的防晒剂积聚在表皮中。通过与SBE7-β-CD复合,紫外线过滤剂在表皮中的浓度显著降低(给药剂量的0.66%),而HP-β-CD则无此作用。SBE7-β-CD使BM-DBM在表皮区域的滞留减少,限制了防晒剂及其光解反应产物与皮肤活性组织的直接接触。